Fetal whole genome sequencing as a clinical diagnostic tool: Advantages, limitations and pitfalls

Best Pract Res Clin Obstet Gynaecol. 2024 Dec:97:102549. doi: 10.1016/j.bpobgyn.2024.102549. Epub 2024 Sep 3.

Abstract

Genome-wide sequencing, which includes exome sequencing and genome sequencing, has revolutionized the diagnostics of genetic disorders in both postnatal and prenatal settings. Compared to exome sequencing, genome sequencing enables the detection of many additional types of genomic variants, although this depends on the bioinformatics pipelines used. Variant classification might vary among laboratories. In the prenatal setting, variant classification may change if new fetal phenotypic features emerge as the pregnancy progresses. There is still a need to evaluate the incremental diagnostic yield of genome sequencing compared to exome sequencing in the prenatal setting. This article reviews the advantages and limitations of genome sequencing, with an emphasis on fetal diagnostics.

Keywords: Case interpretation; Diagnostic yield; Evolving phenotype; Fetal testing; Prenatal genome sequencing; Variant classification.

Publication types

  • Review

MeSH terms

  • Exome Sequencing / methods
  • Female
  • Fetal Diseases / diagnosis
  • Fetal Diseases / genetics
  • Genetic Diseases, Inborn / diagnosis
  • Genetic Diseases, Inborn / genetics
  • Genetic Testing / methods
  • Humans
  • Pregnancy
  • Prenatal Diagnosis* / methods
  • Whole Genome Sequencing* / methods